Read WHO’s detailed update on hydroxychloroquine and the solidarity trial

82,109FansLike
2,966FollowersFollow
2,690SubscribersSubscribe
82,109FansLike
3,122FollowersFollow
2,690SubscribersSubscribe

The World Health Orgnization (WHO) has provided a detailed update on its decision to halt trial for hydroxychloroquine in its quest to find an effective COVID-19 treatment.

“Data from Solidarity (including the French Discovery trial data) and the recently announced results from the UKs Recovery trial both showed that hydroxychloroquine does not result in the reduction of mortality of hospitalised COVID-19 patients, when compared with standard of care,” WHO wrote in a statement on Wednesday.

“Investigators will not randomize further patients to hydroxychloroquine in the Solidarity trial. Patients who have already started hydroxychloroquine but who have not yet finished their course in the trial may complete their course or stop at the discretion of the supervising physician,” i added.

[read_more id="2" more="Read full article" less="Read less"]

Read full statement below 

On June 17, 2020, WHO announced that the hydroxychloroquine (HCQ) arm of the Solidarity Trial to find an effective COVID-19 treatment was being stopped. 

The trial’s Executive Group and principal investigators made the decision based on evidence from the Solidarity Trial, UK’s Recovery trial and a Cochrane review of other evidence on hydroxychloroquine. 

Data from Solidarity (including the French Discovery trial data) and the recently announced results from the UKs Recovery trial both showed that hydroxychloroquine does not result in the reduction of mortality of hospitalised COVID-19 patients, when compared with standard of care. 

Investigators will not randomize further patients to hydroxychloroquine in the Solidarity trial. Patients who have already started hydroxychloroquine but who have not yet finished their course in the trial may complete their course or stop at the discretion of the supervising physician. 

This decision applies only to the conduct of the Solidarity trial and does not apply to the use or evaluation of hydroxychloroquine in pre- or post-exposure prophylaxis in patients exposed to COVID-19.

[/read_more]

Simon Ateba
Simon Ateba
Simon Ateba covers the White House, the U.S. government, the International Monetary Fund, the World Bank and other financial and international institutions for Today News Africa in Washington D.C. Simon can be reached on simonateba@todaynewsafrica.com

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Trending Now

TRENDING

Confidential U.S. government report concludes Ethiopia Prime Minister Abiy Ahmed leading ethnic cleansing in Tigray region

A confidential U.S. government report has concluded that the government of Prime Minister Abiy Ahmed in Ethiopia along with allied militia fighters are leading a systematic campaign of ethnic cleansing in Tigray."Whole villages were severely damaged or completely erased," the report, first obtained by The New York Times, says.It adds that fighters from the neighboring Amhara region of Ethiopia who moved to Tigray...

Stay connected

[/read_more]

[read_more id="2" more="Read full article" less="Read less"]

error: Alert: Content is protected !!
Share
Tweet
Reddit
Pocket
Share
More